Transparent development of the WHO rapid advice guidelines.
Emerging health problems require rapid advice. We describe the development and pilot testing of a systematic, transparent approach used by the World Health Organization (WHO) to develop rapid advice guidelines in response to requests from member states confronted with uncertainty about the pharmacol...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2007-05-01
|
| Series: | PLoS Medicine |
| Online Access: | https://doi.org/10.1371/journal.pmed.0040119 |
| _version_ | 1818843629909704704 |
|---|---|
| author | Holger J Schünemann Suzanne R Hill Meetali Kakad Gunn E Vist Richard Bellamy Lauren Stockman Torbjørn Fosen Wisløff Chris Del Mar Frederick Hayden Timothy M Uyeki Jeremy Farrar Yazdan Yazdanpanah Howard Zucker John Beigel Tawee Chotpitayasunondh Tran Tinh Hien Bülent Ozbay Norio Sugaya Andrew D Oxman |
| author_facet | Holger J Schünemann Suzanne R Hill Meetali Kakad Gunn E Vist Richard Bellamy Lauren Stockman Torbjørn Fosen Wisløff Chris Del Mar Frederick Hayden Timothy M Uyeki Jeremy Farrar Yazdan Yazdanpanah Howard Zucker John Beigel Tawee Chotpitayasunondh Tran Tinh Hien Bülent Ozbay Norio Sugaya Andrew D Oxman |
| author_sort | Holger J Schünemann |
| collection | DOAJ |
| description | Emerging health problems require rapid advice. We describe the development and pilot testing of a systematic, transparent approach used by the World Health Organization (WHO) to develop rapid advice guidelines in response to requests from member states confronted with uncertainty about the pharmacological management of avian influenza A (H5N1) virus infection. We first searched for systematic reviews of randomized trials of treatment and prevention of seasonal influenza and for non-trial evidence on H5N1 infection, including case reports and animal and in vitro studies. A panel of clinical experts, clinicians with experience in treating patients with H5N1, influenza researchers, and methodologists was convened for a two-day meeting. Panel members reviewed the evidence prior to the meeting and agreed on the process. It took one month to put together a team to prepare the evidence profiles (i.e., summaries of the evidence on important clinical and policy questions), and it took the team only five weeks to prepare and revise the evidence profiles and to prepare draft guidelines prior to the panel meeting. A draft manuscript for publication was prepared within 10 days following the panel meeting. Strengths of the process include its transparency and the short amount of time used to prepare these WHO guidelines. The process could be improved by shortening the time required to commission evidence profiles. Further development is needed to facilitate stakeholder involvement, and evaluate and ensure the guideline's usefulness. |
| first_indexed | 2024-12-19T05:00:55Z |
| format | Article |
| id | doaj.art-5a51f17ead154367847cbb1dacf36a6d |
| institution | Directory Open Access Journal |
| issn | 1549-1277 1549-1676 |
| language | English |
| last_indexed | 2024-12-19T05:00:55Z |
| publishDate | 2007-05-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj.art-5a51f17ead154367847cbb1dacf36a6d2022-12-21T20:35:05ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762007-05-0145e11910.1371/journal.pmed.0040119Transparent development of the WHO rapid advice guidelines.Holger J SchünemannSuzanne R HillMeetali KakadGunn E VistRichard BellamyLauren StockmanTorbjørn Fosen WisløffChris Del MarFrederick HaydenTimothy M UyekiJeremy FarrarYazdan YazdanpanahHoward ZuckerJohn BeigelTawee ChotpitayasunondhTran Tinh HienBülent OzbayNorio SugayaAndrew D OxmanEmerging health problems require rapid advice. We describe the development and pilot testing of a systematic, transparent approach used by the World Health Organization (WHO) to develop rapid advice guidelines in response to requests from member states confronted with uncertainty about the pharmacological management of avian influenza A (H5N1) virus infection. We first searched for systematic reviews of randomized trials of treatment and prevention of seasonal influenza and for non-trial evidence on H5N1 infection, including case reports and animal and in vitro studies. A panel of clinical experts, clinicians with experience in treating patients with H5N1, influenza researchers, and methodologists was convened for a two-day meeting. Panel members reviewed the evidence prior to the meeting and agreed on the process. It took one month to put together a team to prepare the evidence profiles (i.e., summaries of the evidence on important clinical and policy questions), and it took the team only five weeks to prepare and revise the evidence profiles and to prepare draft guidelines prior to the panel meeting. A draft manuscript for publication was prepared within 10 days following the panel meeting. Strengths of the process include its transparency and the short amount of time used to prepare these WHO guidelines. The process could be improved by shortening the time required to commission evidence profiles. Further development is needed to facilitate stakeholder involvement, and evaluate and ensure the guideline's usefulness.https://doi.org/10.1371/journal.pmed.0040119 |
| spellingShingle | Holger J Schünemann Suzanne R Hill Meetali Kakad Gunn E Vist Richard Bellamy Lauren Stockman Torbjørn Fosen Wisløff Chris Del Mar Frederick Hayden Timothy M Uyeki Jeremy Farrar Yazdan Yazdanpanah Howard Zucker John Beigel Tawee Chotpitayasunondh Tran Tinh Hien Bülent Ozbay Norio Sugaya Andrew D Oxman Transparent development of the WHO rapid advice guidelines. PLoS Medicine |
| title | Transparent development of the WHO rapid advice guidelines. |
| title_full | Transparent development of the WHO rapid advice guidelines. |
| title_fullStr | Transparent development of the WHO rapid advice guidelines. |
| title_full_unstemmed | Transparent development of the WHO rapid advice guidelines. |
| title_short | Transparent development of the WHO rapid advice guidelines. |
| title_sort | transparent development of the who rapid advice guidelines |
| url | https://doi.org/10.1371/journal.pmed.0040119 |
| work_keys_str_mv | AT holgerjschunemann transparentdevelopmentofthewhorapidadviceguidelines AT suzannerhill transparentdevelopmentofthewhorapidadviceguidelines AT meetalikakad transparentdevelopmentofthewhorapidadviceguidelines AT gunnevist transparentdevelopmentofthewhorapidadviceguidelines AT richardbellamy transparentdevelopmentofthewhorapidadviceguidelines AT laurenstockman transparentdevelopmentofthewhorapidadviceguidelines AT torbjørnfosenwisløff transparentdevelopmentofthewhorapidadviceguidelines AT chrisdelmar transparentdevelopmentofthewhorapidadviceguidelines AT frederickhayden transparentdevelopmentofthewhorapidadviceguidelines AT timothymuyeki transparentdevelopmentofthewhorapidadviceguidelines AT jeremyfarrar transparentdevelopmentofthewhorapidadviceguidelines AT yazdanyazdanpanah transparentdevelopmentofthewhorapidadviceguidelines AT howardzucker transparentdevelopmentofthewhorapidadviceguidelines AT johnbeigel transparentdevelopmentofthewhorapidadviceguidelines AT taweechotpitayasunondh transparentdevelopmentofthewhorapidadviceguidelines AT trantinhhien transparentdevelopmentofthewhorapidadviceguidelines AT bulentozbay transparentdevelopmentofthewhorapidadviceguidelines AT noriosugaya transparentdevelopmentofthewhorapidadviceguidelines AT andrewdoxman transparentdevelopmentofthewhorapidadviceguidelines |